S. Gasso, C. Sunol, C. Sanfeliu, E. Rodriguez-Farre and R. M. Cristofol, “Pharmacological Characterization of the effects of methyl mercury & mercuric chloride on spontaneous nonadrenaline release from rat hippocampal slices”, Life Sci., Vol. 67, 2000, pp. 1219-1231.
 G. Galreunthaier, W. Pialler and P. Kolanka, “Glutathione depletion and invitro lipid peroxidation in mercury or malate induced acute renal failure”, Biochem. Pharmacol., Vol. 32, 1983, pp. 2969-2972.
 G. Discalzi, E. Pira, E. Herrero-Hernandez, C. Valentini, M. Turbiglio and F. Meliga, “Occupational Mn parkinsonism: magnetic resonance imaging and clinical patterns following CaNa2-EDTA chelation”, Neurotoxicology, Vol. 21, 2000, pp. 863-866.
 S. Araragi, M. Kondoh, M. Kawase, S. Saito, M. Higashimoto and M. Sato, “Mercuric chloride induces apoptosis via a mitochondrial-dependent pathway in human leukemia cells,” Toxicology, Vol. 184, 2003, pp. 1-9.
 J. C. Pendergrass and B. E. Haley, “The Toxic Effects of Mercury on CNS Proteins: Similarity to Observations in Alzheimer’s Disease”, Univ. Of Kentucky Dept. Of Chemistry, 1997a, IAOMT Symposium paper.
 C. Hock, G. Drasch, S. Golombowski, F. Muller-Spahn, B. Willer-Shausen-Zonnchen, P. Schwarz, U. Hock, J. H. Growdon and R. M. Nitsch, “Increased blood mercury levels in patients with Alzheimer’s disease”, J. Neural Transm., Vol. 105, 1998, pp. 59-68.
 S. Belletti and R. Gatti, “Time course assessment of methylmercury effects on C6 glioma cells: submicromolar concentrations induce oxidative DNA damage and apoptosis”, J. Neurosci. Res., Vol. 70, 2002, pp. 703-711.
 T. Kjelstrom, P. Kennedy, S. Wallis, A. Stewart, L. Friberg and B. Lind, 1989. ”Physical and mental development of children with prenatal exposure to mercury from fish. Stage II: Interviews and psychological tests at age 6”, Solna: National Swedish Environmental Protection Board Report.
 P. Grandjean, P. Weihe, R. F. White, F. Debes, S. Araki and K. Yokoyama, “Cognitive deficit in 7-year-old children with prenatal exposure to methyl mercury”, Neurotoxicol. Teratol., Vol. 19, 1997, pp.417-428.
 P. Grandjean, E. Budtz-Jorgensen, R. F. White, P. J. Jorgensen, P. Weihe and F. Debes, 1999. “Methyl mer- cury exposure biomarkers as indicators of neurotoxicity in children aged 7 years”, Am. J. Epidemiol., Vol. 150, 1999, pp. 301-305.
 H. Fukine, M. Hirai, Y. M. Rsuch and Y. Yamane, “Effect of zinc pretreatment on mercuric chloride-induced lipid peroxidation in the rat kidney”, Toxicol. Appl. Pharmacol., Vol. 73, 1984, pp. 395-401.
 N. Basu, A. M. Scheuhammer, R. D. Evans, M. O’Brien and L H. M. Chan, “Cholinesterase and monoamine oxidase activity in relation to mercury levels in the cerebral cortex of wild river otters”, Human and Experimental Toxicology, Vol. 3, 2007, pp. 213-220.
 N, Basu, A. M. Scheuhammer, K. Rouvinen-Watt, R. D. Evans, N. Grochowina N and L. H. Chan, “The effects of mercury on muscarinic cholinergic receptor subtypes (M1 and M2) in captive mink”, Neurotoxicology, Vol. 29, 2008, pp. 328-334.
 R. J. Reiter, D. X. Tan, J. C. Mayo, R. M. Sainz, J. Leon, Z. Czarnocki, “Melatonin as an antioxidant; Biochemical mechanisms and pathophysiological implications”, Acta Biochem. Polon., Vol. 50, 2003, pp. 1129-1146.
 I. Antolin, C. Rodriguez, R. M. Sainz, J. Mayo, H. Uria, M. L. Kotler, M. J. Rodriguez-Colunga, D. Tolivia and A. Menendez Pelaez, “Neurohormone melatonin prevents cell damage: effect on gene expression for antioxidant enzymes,” FASEB J., Vol.10, 1996, pp. 882-890.
 C. Rodriguez, J. C. Mayo, R. M. Sainz, I. Antolin, F. Herrera, V. Martin and R. J. Reiter, “Regulation of antioxidant enzymes: A significant role for melatonin”, J. Pineal Res., Vol. 36, 2004, pp. 1-9.
 S. Lopez-Burillo, D. X. Tan, J. C. Mayo, R. M. Sainz and R. J. Reiter, “Melatonin xanthurenic acid reveratrol, EGCG, Vitamin C and alpha-lipoic acid differentially reduce oxidative DNA damage induced by Fenton reagents, a study of their individual and synergistic actions”, J. Pineal. Res., Vol. 34, 2003, pp. 269-277.
 R. J. Reiter, D. Melchiorri, E. Sewerynek, B. Poeggeler, L. Barlow-Walden, J. Chuang, G. G. Ortiz and D. A. Acuna-Castroviejo, “A review of the evidence supporting melatonin’s role as an antioxidant”, J. Pineal Res., Vol. 18, 1995, pp. 1-18.
 B. O. Lund, D. M. Miller and J. S. Woods, “Studies on Hg (II)–induced H2O2 formation and oxidative stress in vivo and vitro in rat kidney mitochondria”, Biochem. Pharmacol., Vol. 45, 1993, pp. 2017 2024.
 J. T. Rotruck, A. L. Pope, H. E. Ganther, A. B. Swanson, D. G. Hafeman and W.G. Hoekstra, “Selenium: Biochemical roles as a component of glutathione peroxidase”, Sci., Vol. 179, 1973, pp. 585-590.
 E. Pick and Y. Keisari, “Superoxide anion and hydrogen peroxide production by chemically elicited peritoneal macrophages-Induction by multiple non phagocytic stimuli”, Cellular Immunology, Vol. 59, 1981, pp. 301-318.
 J. H. Roe and C. A. Kuether, “The determination of ascorbic acid in whole blood and urine through the 2, 4-dinitrophenyl hydrazine derivatives of dehydroascorbic acid”, J. Biol. Chem., Vol.147, 1943, pp. 399-407.
 F. H. El-Rashidy, W. A. Al-Turk and S. J. Stohs, “Glutathione, Glutathione reductase and Glutathione S-trans- ferase activities in erythrocytes and lymphocytes in chronic renal disease”, Res. Commun. Chem. Pharm., Vol. 44, 1984, pp. 423-429.
 R. Franco, O. J. Schoneveld, A. Pappa and M. I. Panayiotidis 2007. “The central role of glutathione in the pathophysiology of human diseases”, Arch. Physiol. Biochem., Vol. 113, 2007, pp. 234-258.
 V. H. Neefjes, C. T. Evelo, L. G. Baars and L. E. Blanco, “Erythrocyte Glutathione-S transferase as a marker of oxidative stress at birth”, Arch. Dis. Child Fetal Neonatal, Vol. 81, 1999, pp.130-133.
 S. Hussain, D. A. Rodgers, H. M. Duhart and S. F. Ali, “Mercuric chloride-induced reactive oxygen species and its effect on antioxidant enzymes in different regions of rat brain”, J. Environ. Sci. Health, Vol. 32, 1997, pp. 359-409.
 S. D. Vinay, K. G. Raghu and P. P. Sood, “Dose and duration related methyl mercury deposition, glucosidase inhibition, myelin degeneration and chelating therapy”, Cell Mol. Biol., Vol. 36, 1990, pp. 609-623.
 R. J. Reiter, D. X. Tan, L. C. Manchester and I. L. Tamura, “Melatonin defeats neutrally-derived free radicals and reduces the associated neuromorphological and neurobehavioral damage”, J. of Physiol. and Pharmacol., Vol. 38, 2007, pp. 3-22.
 Y. Quiroz, A. Ferrebuz, F. Romero, N. D. Vaziri and R. I. Bernardo, “Melatonin ameliorates oxidative stress, inflammation, proteinuria, and progression of renal damage in rats with renal mass reduction”, Am. J. Physiol. Renal Physiol., Vol. 294, 2008, pp. 336-344.